Cover Image
Market Research Report

Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Published by Transparency Market Research Product code 600060
Published Content info 285 Pages
Delivery time: 1-2 business days
Price
Back to Top
Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
Published: October 26, 2018 Content info: 285 Pages
Description

Title:
Pneumococcal Vaccines Market (Product - Synflorix, Prevenar-13, PCV 13, V114, PCV-20, PCV-10, PPSV-23; Distribution Channel - Wholesalers (pharmacy channel), Specialized Companies, Public Authorities; Sector - Public, Private) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026.

Global Pneumococcal Vaccines Market: Overview

This report analyzes the current and future scenario of the global pneumococcal vaccines market. Increase in patient population, growth of the pharmaceutical industry, rise in government investments for vaccination programs, improvement in health care infrastructure, and surge in the number of clinical trials are projected to be the major drivers of the global market during the forecast period.

The global pneumococcal vaccines market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product type, distribution channel, sector, and region. A detailed qualitative analysis of drivers and restraints of the market, and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global pneumococcal vaccines market.

Global Pneumococcal Vaccines Market: Key Segments

Based on product type, the global pneumococcal vaccines market has been segmented into Synflorix, Prevenar-13, PCV 13 (pipeline), V114 (Merck), PCV-20 (Pfizer), PCV-10 (SII), and PPSV- 23. Each of these segments is categorized into pediatric and adults. In terms of distribution channel, the global market has been classified into wholesalers (pharmacy channel), specialized companies, public authorities, and others. Based on sector, the market has been bifurcated into private and public. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Pneumococcal Vaccines Market: Regional Outlook

In terms of region, the global pneumococcal vaccines market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, Belgium, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Rest of the World (Middle East and Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global pneumococcal vaccines market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players profiled in the market report include Pfizer, Inc., Merck & Co., Inc., SK Chemicals, Serum Institute of India Pvt. Ltd., Chengdu Institute of Biological Products Co., Ltd., GlaxoSmithKline plc, Sanofi, and Walvax Biotechnology Co., Ltd.

The global pneumococcal vaccines market has been segmented as below:

Global Pneumococcal Vaccines Market, by Product Type

  • Synflorix
    • Pediatric
    • Adult
  • Prevenar-13
    • Pediatric
    • Adult
  • PCV 13 (pipeline)
    • Pediatric
    • Adult
  • V114 (Merck)
    • Pediatric
    • Adult
  • PCV-20 (Pfizer)
    • Pediatric
    • Adult
  • PCV-10 (SII)
    • Pediatric
    • Adult
  • PPSV- 23
    • Pediatric
    • Adult

Global Pneumococcal Vaccines Market, by Distribution Channel

  • Wholesalers (pharmacy channel)
  • Specialized Companies
  • Public Authorities
  • Others

Global Pneumococcal Vaccines Market, by Sector

  • Public
  • Private

Global Pneumococcal Vaccines Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • Spain
    • Belgium
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Rest of the World
    • Middle East
    • Africa
Table of Contents

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions and Acronyms Used
  • 2.2. Research Methodology

3. Executive Summary

  • 3.1. Global Pneumococcal Vaccines Market Size (US$ Mn) and Distribution, by Region, 2018 and 2026
  • 3.2. Global Pneumococcal Vaccines Market: Market Snapshot, 2016

4. Market Overview

  • 4.1. Overview
  • 4.2. Global Pneumococcal Vaccines Market Size (US$ Mn) Forecast, 2016-2026
  • 4.3. Global Pneumococcal Vaccines Market Outlook
  • 4.4. Approved & Pipeline Products Snapshot

5. Market Dynamics

  • 5.1. Drivers
    • 5.1.1. Government participation in design & implementation of comprehensive vaccination programs
    • 5.1.2. Increase in investments by public & private players in R&D of conjugate pneumococcal vaccines
  • 5.2. Restraints
    • 5.2.1. Longer timeline and high cost associated with development of pneumococcal vaccines
  • 5.3. Opportunities
    • 5.3.1. Development of multivalent conjugated vaccines with different serotypes
  • 5.4. Trends
    • 5.4.1. Public-Private Partnerships

6. Global Pneumococcal Vaccines Market Analysis, by Product Type

  • 6.1. Introduction
  • 6.2. Global Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 6.3. Pneumococcal Vaccines Market Analysis, by Product Type
    • 6.3.1. Synflorix
      • 6.3.1.1. Pediatric
      • 6.3.1.2. Adult
    • 6.3.2. Prevenar-13
      • 6.3.2.1. Pediatric
      • 6.3.2.2. Adult
    • 6.3.3. PCV 13 (pipeline)
      • 6.3.3.1. Pediatric
      • 6.3.3.2. Adult
    • 6.3.4. V114 (Merck)
      • 6.3.4.1. Pediatric
      • 6.3.4.2. Adult
    • 6.3.5. PCV-20 (Pfizer)
      • 6.3.5.1. Pediatric
      • 6.3.5.2. Adult
    • 6.3.6. PCV-10 (SII)
      • 6.3.6.1. Pediatric
      • 6.3.6.2. Adult
    • 6.3.7. PPSV- 23
      • 6.3.7.1. Pediatric
      • 6.3.7.2. Adult

7. Global Pneumococcal Vaccines Market Analysis, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Global Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 7.3. Pneumococcal Vaccines Market Analysis, by Distribution Channel
    • 7.3.1. Wholesalers
    • 7.3.2. Specialized Companies
    • 7.3.3. Public Authorities
    • 7.3.4. Others

8. Global Pneumococcal Vaccines Market Analysis, by Sector

  • 8.1. Introduction
  • 8.2. Global Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 8.3. Pneumococcal Vaccines Market Analysis, by Sector
    • 8.3.1. Public
    • 8.3.2. Private

9. U.S. Pneumococcal Vaccines Market Analysis

  • 9.1. U.S. Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 9.2. U.S. Pneumococcal Vaccines Market Forecast, by Product Type
    • 9.2.1. Prevanar-13
    • 9.2.2. V114
    • 9.2.3. PCV-20
    • 9.2.4. Pneumovax-23
  • 9.3. U.S. Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 9.4. U.S. Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 9.4.1. Wholesalers
    • 9.4.2. Specialized Companies
    • 9.4.3. Public Authorities
    • 9.4.4. Others
  • 9.5. U.S. Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 9.6. U.S. Pneumococcal Vaccines Market Forecast, by Sector
    • 9.6.1. Private
    • 9.6.2. Public
  • 10. Canada Pneumococcal Vaccines Market Analysis
  • 10.1. Canada Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 10.2. Canada Pneumococcal Vaccines Market Forecast, by Product Type
    • 10.2.1. Prevenar-13
    • 10.2.2. Synflorix
    • 10.2.3. V-114
    • 10.2.4. Pneumo - 23
    • 10.2.5. Pnuemovax-23
  • 10.3. Canada Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 10.4. Canada Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 10.4.1. Wholesalers
    • 10.4.2. Specialized Companies
    • 10.4.3. Public Authorities
    • 10.4.4. Others
  • 10.5. Canada Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 10.6. Canada Pneumococcal Vaccines Market Forecast, by Sector
    • 10.6.1. Private
    • 10.6.2. Public

11. Germany Pneumococcal Vaccines Market Analysis

  • 11.1. Germany Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 11.2. Germany Pneumococcal Vaccines Market Forecast, by Product Type
    • 11.2.1. Prevenar-13
    • 11.2.2. Synflorix
    • 11.2.3. V-114
    • 11.2.4. PCV-20
    • 11.2.5. Pnuemovax-23
  • 11.3. Germany Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 11.4. Germany Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 11.4.1. Wholesalers
    • 11.4.2. Specialized Companies
    • 11.4.3. Public Authorities
    • 11.4.4. Others
  • 11.5. Germany Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 11.6. Germany Pneumococcal Vaccines Market Forecast, by Sector
    • 11.6.1. Private
    • 11.6.2. Public

12. U.K. Pneumococcal Vaccines Market Analysis

  • 12.1. U.K. Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 12.2. U.K. Pneumococcal Vaccines Market Forecast, by Product Type
    • 12.2.1. Prevenar-13
    • 12.2.2. Synflorix
    • 12.2.3. V-114
    • 12.2.4. PCV-20
    • 12.2.5. Pnuemovax-23
  • 12.3. U.K. Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 12.4. U.K. Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 12.4.1. Wholesalers
    • 12.4.2. Specialized Companies
    • 12.4.3. Public Authorities
    • 12.4.4. Others
  • 12.5. U.K. Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 12.6. U.K. Pneumococcal Vaccines Market Forecast, by Sector
    • 12.6.1. Private
    • 12.6.2. Public

13. France Pneumococcal Vaccines Market Analysis

  • 13.1. France Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 13.2. France Pneumococcal Vaccines Market Forecast, by Product Type
    • 13.2.1. Prevenar-13
    • 13.2.2. Synflorix
    • 13.2.3. V-114
    • 13.2.4. PCV-20
    • 13.2.5. Pnuemovax-23
  • 13.3. France Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 13.4. France Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 13.4.1. Wholesalers
    • 13.4.2. Specialized Companies
    • 13.4.3. Public Authorities
    • 13.4.4. Others
  • 13.5. France Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 13.6. France Pneumococcal Vaccines Market Forecast, by Sector
    • 13.6.1. Private
    • 13.6.2. Public

14. Italy Pneumococcal Vaccines Market Analysis

  • 14.1. Italy Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 14.2. Italy Pneumococcal Vaccines Market Forecast, by Product Type
    • 14.2.1. Prevenar-13
    • 14.2.2. Synflorix
    • 14.2.3. V-114
    • 14.2.4. PCV-20
    • 14.2.5. Pnuemovax-23
  • 14.3. Italy Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 14.4. Italy Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 14.4.1. Wholesalers
    • 14.4.2. Specialized Companies
    • 14.4.3. Public Authorities
    • 14.4.4. Others
  • 14.5. Italy Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 14.6. Italy Pneumococcal Vaccines Market Forecast, by Sector
    • 14.6.1. Private
    • 14.6.2. Public

15. Spain Pneumococcal Vaccines Market Analysis

  • 15.1. Spain Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 15.2. Spain Pneumococcal Vaccines Market Forecast, by Product Type
    • 15.2.1. Prevenar-13
    • 15.2.2. Synflorix
    • 15.2.3. V-114
    • 15.2.4. PCV-20
    • 15.2.5. Pnuemovax-23
  • 15.3. Spain Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 15.4. Spain Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 15.4.1. Wholesalers
    • 15.4.2. Specialized Companies
    • 15.4.3. Public Authorities
    • 15.4.4. Others
  • 15.5. Spain Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 15.6. Spain Pneumococcal Vaccines Market Forecast, by Sector
    • 15.6.1. Private
    • 15.6.2. Public

16. Belgium Pneumococcal Vaccines Market Analysis

  • 16.1. Belgium Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 16.2. Belgium Pneumococcal Vaccines Market Forecast, by Product Type
    • 16.2.1. Prevenar-13
    • 16.2.2. Synflorix
    • 16.2.3. V-114
    • 16.2.4. PCV-20
    • 16.2.5. Pnuemovax-23
  • 16.3. Belgium Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 16.4. Belgium Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 16.4.1. Wholesalers
    • 16.4.2. Specialized Companies
    • 16.4.3. Public Authorities
    • 16.4.4. Others
  • 16.5. Belgium Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 16.6. Belgium Pneumococcal Vaccines Market Forecast, by Sector
    • 16.6.1. Private
    • 16.6.2. Public

17. India Pneumococcal Vaccines Market Analysis

  • 17.1. India Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 17.2. India Pneumococcal Vaccines Market Forecast, by Product Type
    • 17.2.1. Prevenar-13
    • 17.2.2. Synflorix
    • 17.2.3. SIIL PCV-10
    • 17.2.4. PCV-20
    • 17.2.5. Pnuemovax-23
  • 17.3. India Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 17.4. India Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 17.4.1. Wholesalers
    • 17.4.2. Specialized Companies
    • 17.4.3. Public Authorities
    • 17.4.4. Others
  • 17.5. India Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 17.6. India Pneumococcal Vaccines Market Forecast, by Sector
    • 17.6.1. Private
    • 17.6.2. Public

18. China Pneumococcal Vaccines Market Analysis

  • 18.1. China Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 18.2. China Pneumococcal Vaccines Market Forecast, by Product Type
    • 18.2.1. Prevenar-13
    • 18.2.2. PCV 13 (pipeline)
    • 18.2.3. PPSV 23
  • 18.3. China Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 18.4. China Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 18.4.1. Wholesalers
    • 18.4.2. Specialized Companies
    • 18.4.3. Public Authorities
    • 18.4.4. Others
  • 18.5. China Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 18.6. China Pneumococcal Vaccines Market Forecast, by Sector
    • 18.6.1. Private
    • 18.6.2. Public

19. Japan Pneumococcal Vaccines Market Analysis

  • 19.1. Japan Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 19.2. Japan Pneumococcal Vaccines Market Forecast, by Product Type
    • 19.2.1. Prevenar-13
    • 19.2.2. Synflorix
    • 19.2.3. PPSV 23
  • 19.3. Japan Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 19.4. Japan Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 19.4.1. Wholesalers
    • 19.4.2. Specialized Companies
    • 19.4.3. Public Authorities
    • 19.4.4. Others
  • 19.5. Japan Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 19.6. Japan Pneumococcal Vaccines Market Forecast, by Sector
    • 19.6.1. Private
    • 19.6.2. Public

20. Australia Pneumococcal Vaccines Market Analysis

  • 20.1. Australia Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 20.2. Australia Pneumococcal Vaccines Market Forecast, by Product Type
    • 20.2.1. Prevenar-13
    • 20.2.2. Synflorix
    • 20.2.3. V114
    • 20.2.4. Pnuemovax-23
  • 20.3. Australia Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 20.4. Australia Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 20.4.1. Wholesalers
    • 20.4.2. Specialized Companies
    • 20.4.3. Public Authorities
    • 20.4.4. Others
  • 20.5. Australia Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 20.6. Australia Pneumococcal Vaccines Market Forecast, by Sector
    • 20.6.1. Private
    • 20.6.2. Public

21. New Zealand Pneumococcal Vaccines Market Analysis

  • 21.1. New Zealand Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 21.2. New Zealand Pneumococcal Vaccines Market Forecast, by Product Type
    • 21.2.1. Prevenar-13
    • 21.2.2. Synflorix
    • 21.2.3. Pnuemovax-23
  • 21.3. New Zealand Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 21.4. New Zealand Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 21.4.1. Wholesalers
    • 21.4.2. Specialized Companies
    • 21.4.3. Public Authorities
    • 21.4.4. Others
  • 21.5. New Zealand Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 21.6. New Zealand Pneumococcal Vaccines Market Forecast, by Sector
    • 21.6.1. Private
    • 21.6.2. Public

22. Brazil Pneumococcal Vaccines Market Analysis

  • 22.1. Brazil Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 22.2. Brazil Pneumococcal Vaccines Market Forecast, by Product Type
    • 22.2.1. Prevenar-13
    • 22.2.2. Synflorix
    • 22.2.3. Pnuemovax-23
  • 22.3. Brazil Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 22.4. Brazil Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 22.4.1. Wholesalers
    • 22.4.2. Specialized Companies
    • 22.4.3. Public Authorities
    • 22.4.4. Others
  • 22.5. Brazil Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 22.6. Brazil Pneumococcal Vaccines Market Forecast, by Sector
    • 22.6.1. Private
    • 22.6.2. Public

23. Mexico Pneumococcal Vaccines Market Analysis

  • 23.1. Mexico Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 23.2. Mexico Pneumococcal Vaccines Market Forecast, by Product Type
    • 23.2.1. Prevenar-13
    • 23.2.2. Synflorix
    • 23.2.3. Pnuemovax-23
  • 23.3. Mexico Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 23.4. Mexico Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 23.4.1. Wholesalers
    • 23.4.2. Specialized Companies
    • 23.4.3. Public Authorities
    • 23.4.4. Others
  • 23.5. Mexico Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 23.6. Mexico Pneumococcal Vaccines Market Forecast, by Sector
    • 23.6.1. Private
    • 23.6.2. Public

24. Rest of the World Pneumococcal Vaccines Market Analysis

  • 24.1. Rest of the World Pneumococcal Vaccines Market Value Share Analysis, by Product Type
  • 24.2. Rest of the World Pneumococcal Vaccines Market Forecast, by Product Type
    • 24.2.1. Prevenar-13
    • 24.2.2. Synflorix
    • 24.2.3. V-114
    • 24.2.4. PCV-20
    • 24.2.5. PCV-10 (SII)
    • 24.2.6. Pnuemovax-23
  • 24.3. Rest of the World Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
  • 24.4. Rest of the World Pneumococcal Vaccines Market Forecast, by Distribution Channel
    • 24.4.1. Wholesalers
    • 24.4.2. Specialized Companies
    • 24.4.3. Public Authorities
    • 24.4.4. Others
  • 24.5. Rest of the World Pneumococcal Vaccines Market Value Share Analysis, by Sector
  • 24.6. Rest of the World Pneumococcal Vaccines Market Forecast, by Sector
    • 24.6.1. Private
    • 24.6.2. Public
  • 24.7. Rest of the World Pneumococcal Vaccines Market Forecast, by Region

25. Competition Landscape

  • 25.1. Global Pneumococcal Vaccines Market Share Analysis, by Company (2017)
  • 25.2. Company Profiles
    • 25.2.1. Pfizer, Inc.
    • 25.2.2. Merck & Co., Inc.
    • 25.2.3. SK Chemicals
    • 25.2.4. Serum Institute of India Pvt. Ltd.
    • 25.2.5. Chengdu Institute of Biological Products Co., Ltd.
    • 25.2.6. GlaxoSmithKline plc
    • 25.2.7. Sanofi
    • 25.2.8. Walvax Biotechnology Co., Ltd.

List of Tables

  • TABLE 1 Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 2 Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 3 Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 4 U.S. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 5 U.S. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 6 U.S. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 7 U.S. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 8 Canada Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 9 Canada Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 10 Canada Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 11 Canada Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 12 Germany Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 13 Germany Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 14 Germany Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 15 Germany Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 16 U.K. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 17 U.K. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 18 U.K. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 19 U.K. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 20 France Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 21 France Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 22 France Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 23 France Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 24 Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 25 Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 26 Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 27 Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 28 Spain Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 29 Spain Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 30 Spain Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 31 Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 32 Belgium Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 33 Belgium Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 34 Belgium Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 35 Belgium Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 36 India Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 37 India Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 38 India Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 39 India Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 40 China Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 41 China Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 42 China Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 43 China Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 44 Japan Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 45 Japan Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 46 Japan Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 47 Japan Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 48 Australia Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 49 Australia Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 50 Australia Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 51 Australia Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 52 New Zealand Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 53 New Zealand Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 54 New Zealand Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 55 New Zealand Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 56 Brazil Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 57 Brazil Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 58 Brazil Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 59 Brazil Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 60 Mexico Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 61 Mexico Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 62 Mexico Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 63 Mexico Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 64 Rest of the World (RoW) Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 65 Rest of the World (RoW) Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • TABLE 66 Rest of the World (RoW) Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • TABLE 67 Rest of the World (RoW) Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016-2026
  • TABLE 68 Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Region, 2016-2026
  • TABLE 69 North America Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Country, 2016-2026
  • TABLE 70 Europe Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • TABLE 71 Asia Pacific Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • TABLE 72 Latin America Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026

List of Figures

  • FIG. 1 Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, 2016-2026
  • FIG. 2 Global Pneumococcal Vaccines Market Value Share (%), by Product Type (2017)
  • FIG. 3 Global Pneumococcal Vaccines Market Value Share (%), by Sector (2017)
  • FIG. 4 Global Pneumococcal Vaccines Market Value Share (%), by Distribution Channel (2017)
  • FIG. 5 Global Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 6 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 10-Valent, 2016-2026
  • FIG. 7 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 10-Valent (pipeline), 2016-2026
  • FIG. 8 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 13-Valent, 2016-2026
  • FIG. 9 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 13-Valent (pipeline), 2016-2026
  • FIG. 10 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 15-Valent (pipeline), 2016-2026
  • FIG. 11 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 20-Valent (pipeline), 2016-2026
  • FIG. 12 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 23-Valent, 2016-2026
  • FIG. 13 Global Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 14 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Wholesalers, 2016-2026
  • FIG. 15 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Specialized Companies, 2016-2026
  • FIG. 16 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Public Authorities, 2016-2026
  • FIG. 17 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016-2026
  • FIG. 18 Global Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 19 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Public, 2016-2026
  • FIG. 20 Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Private, 2016-2026
  • FIG. 21 U.S. Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 22 U.S. Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 23 U.S. Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 24 Canada Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 25 Canada Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 26 Canada Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 27 Germany Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 28 Germany Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 29 Germany Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 30 U.K. Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 31 U.K. Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 32 U.K. Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 33 France Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 34 France Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 35 France Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 36 Italy Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 37 Italy Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 38 Italy Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 39 Spain Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 40 Spain Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 41 Spain Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 42 Belgium Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 43 Belgium Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 44 Belgium Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 45 India Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 46 India Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 47 India Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 48 China Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 49 China Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 50 China Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 51 Japan Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 52 Japan Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 53 Japan Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 54 New Zealand Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 55 Australia Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 56 Australia Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 57 New Zealand Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 58 New Zealand Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 59 New Zealand Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 60 Brazil Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 61 Brazil Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 62 Brazil Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 63 Mexico Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 64 Mexico Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 65 Mexico Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 66 Rest of the World (RoW) Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
  • FIG. 67 Rest of the World (RoW) Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
  • FIG. 68 Rest of the World (RoW) Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
  • FIG. 69 Global Pneumococcal Vaccines Market Share (%) and Market Share Range (%), by Company, 2017
Back to Top